Literature DB >> 26868732

Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug development.

David Tweedie1, Lital Rachmany2, Dong Seok Kim3, Vardit Rubovitch2, Elin Lehrmann4, Yongqing Zhang4, Kevin G Becker4, Evelyn Perez5, Chaim G Pick6, Nigel H Greig7.   

Abstract

BACKGROUND: Neurological dysfunction after traumatic brain injury (TBI) poses short-term or long-lasting health issues for family members and health care providers. Presently there are no approved medicines to treat TBI. Epidemiological evidence suggests that TBI may cause neurodegenerative disease later in life. In an effort to illuminate target cellular processes for drug development, we examined the effects of a mild TBI on hippocampal gene expression in mouse.
METHODS: mTBI was induced in a closed head, weight drop-system in mice (ICR). Animals were anesthetized and subjected to mTBI (30g). Fourteen days after injury the ipsilateral hippocampus was utilized for cDNA gene array studies. mTBI animals were compared with sham-operated animals. Genes regulated by TBI were identified to define TBI-induced physiological/pathological processes. mTBI regulated genes were divided into functional groupings to provide gene ontologies. Genes were further divided to identify molecular/cellular pathways regulated by mTBI.
RESULTS: Numerous genes were regulated after a single mTBI event that mapped to many ontologies and molecular pathways related to inflammation and neurological physiology/pathology, including neurodegenerative disease.
CONCLUSIONS: These data illustrate diverse transcriptional changes in hippocampal tissues triggered by a single mild injury. The systematic analysis of individual genes that lead to the identification of functional categories, such as gene ontologies and then molecular pathways, illustrate target processes of relevance to TBI pathology. These processes may be further dissected to identify key factors that can be evaluated at the protein level to highlight possible treatments for TBI in human disease and potential biomarkers of neurodegenerative processes. Published by Elsevier B.V.

Entities:  

Keywords:  Dementia; Gene expression; Gene ontology; Inflammation; Mild traumatic brain injury (mTBI); Molecular pathway; Neurodegeneration; Neurological

Mesh:

Year:  2016        PMID: 26868732      PMCID: PMC4977213          DOI: 10.1016/j.jneumeth.2016.02.003

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  70 in total

Review 1.  The effectiveness of donepezil for cognitive rehabilitation after traumatic brain injury: a systematic review.

Authors:  Javier Ballesteros; Itziar Güemes; Nora Ibarra; José I Quemada
Journal:  J Head Trauma Rehabil       Date:  2008 May-Jun       Impact factor: 2.710

2.  Selective CDK inhibitor limits neuroinflammation and progressive neurodegeneration after brain trauma.

Authors:  Shruti V Kabadi; Bogdan A Stoica; Kimberly R Byrnes; Marie Hanscom; David J Loane; Alan I Faden
Journal:  J Cereb Blood Flow Metab       Date:  2011-08-10       Impact factor: 6.200

Review 3.  Lost in translation: neuropsychiatric drug development.

Authors:  Robert E Becker; Nigel H Greig
Journal:  Sci Transl Med       Date:  2010-12-08       Impact factor: 17.956

4.  Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.

Authors:  Yazhou Li; Miaad Bader; Chaim G Pick; Nigel H Greig; Ian Tamargo; Vardit Rubovitch; David Tweedie
Journal:  J Neurochem       Date:  2015-06-18       Impact factor: 5.372

Review 5.  Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disorders.

Authors:  Isidro Salcedo; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

Review 6.  Insulin, incretins and other growth factors as potential novel treatments for Alzheimer's and Parkinson's diseases.

Authors:  Christian Hölscher
Journal:  Biochem Soc Trans       Date:  2014-04       Impact factor: 5.407

7.  Early TBI-Induced Cytokine Alterations are Similarly Detected by Two Distinct Methods of Multiplex Assay.

Authors:  Sanjib Mukherjee; Khurshed Katki; Gabriel M Arisi; Maira L Foresti; Lee A Shapiro
Journal:  Front Mol Neurosci       Date:  2011-09-16       Impact factor: 5.639

8.  Cognitive impairments accompanying rodent mild traumatic brain injury involve p53-dependent neuronal cell death and are ameliorated by the tetrahydrobenzothiazole PFT-α.

Authors:  Lital Rachmany; David Tweedie; Vardit Rubovitch; Qian-Sheng Yu; Yazhou Li; Jia-Yi Wang; Chaim G Pick; Nigel H Greig
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

Review 9.  Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date.

Authors:  Antonino Tuttolomondo; Rosaria Pecoraro; Antonio Pinto
Journal:  Drug Des Devel Ther       Date:  2014-11-07       Impact factor: 4.162

10.  Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy.

Authors:  Asami Kondo; Koorosh Shahpasand; Rebekah Mannix; Jianhua Qiu; Juliet Moncaster; Chun-Hau Chen; Yandan Yao; Yu-Min Lin; Jane A Driver; Yan Sun; Shuo Wei; Man-Li Luo; Onder Albayram; Pengyu Huang; Alexander Rotenberg; Akihide Ryo; Lee E Goldstein; Alvaro Pascual-Leone; Ann C McKee; William Meehan; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nature       Date:  2015-07-15       Impact factor: 49.962

View more
  12 in total

1.  (-)-Phenserine and the prevention of pre-programmed cell death and neuroinflammation in mild traumatic brain injury and Alzheimer's disease challenged mice.

Authors:  Daniela Lecca; Miaad Bader; David Tweedie; Alexander F Hoffman; Yoo Jin Jung; Shin-Chang Hsueh; Barry J Hoffer; Robert E Becker; Chaim G Pick; Carl R Lupica; Nigel H Greig
Journal:  Neurobiol Dis       Date:  2019-07-08       Impact factor: 5.996

2.  RhoA Inhibitor Treatment At Acute Phase of Spinal Cord Injury May Induce Neurite Outgrowth and Synaptogenesis.

Authors:  Stephanie Devaux; Dasa Cizkova; Khalil Mallah; Melodie Anne Karnoub; Zahra Laouby; Firas Kobeissy; Juraj Blasko; Serge Nataf; Laurent Pays; Céline Mériaux; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2017-06-28       Impact factor: 5.911

Review 3.  Neuroinflammation in animal models of traumatic brain injury.

Authors:  Chong-Chi Chiu; Yi-En Liao; Ling-Yu Yang; Jing-Ya Wang; David Tweedie; Hanuma K Karnati; Nigel H Greig; Jia-Yi Wang
Journal:  J Neurosci Methods       Date:  2016-07-02       Impact factor: 2.390

4.  N-Adamantyl Phthalimidine: A New Thalidomide-like Drug That Lacks Cereblon Binding and Mitigates Neuronal and Synaptic Loss, Neuroinflammation, and Behavioral Deficits in Traumatic Brain Injury and LPS Challenge.

Authors:  Shih Chang Hsueh; Weiming Luo; David Tweedie; Dong Seok Kim; Yu Kyung Kim; Inho Hwang; Jung-Eun Gil; Baek-Soo Han; Yung-Hsiao Chiang; Warren Selman; Barry J Hoffer; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-30

5.  Temporal Changes in Cortical and Hippocampal Expression of Genes Important for Brain Glucose Metabolism Following Controlled Cortical Impact Injury in Mice.

Authors:  June Zhou; Mark P Burns; Linda Huynh; Sonia Villapol; Daniel D Taub; Juan M Saavedra; Marc R Blackman
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-11       Impact factor: 5.555

6.  Recovery from trauma induced amnesia correlates with normalization of thrombin activity in the mouse hippocampus.

Authors:  Marina Ben Shimon; Talya Zeimer; Efrat Shavit Stein; Avital Artan-Furman; Sagi Harnof; Joab Chapman; Arik Eisenkraft; Chaim G Pick; Nicola Maggio
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

7.  Older Age Results in Differential Gene Expression after Mild Traumatic Brain Injury and Is Linked to Imaging Differences at Acute Follow-up.

Authors:  Young-Eun Cho; Lawrence L Latour; Hyungsuk Kim; L Christine Turtzo; Anlys Olivera; Whitney S Livingston; Dan Wang; Christiana Martin; Chen Lai; Ann Cashion; Jessica Gill
Journal:  Front Aging Neurosci       Date:  2016-07-13       Impact factor: 5.750

8.  A Systematic Review of Closed Head Injury Models of Mild Traumatic Brain Injury in Mice and Rats.

Authors:  Colleen N Bodnar; Kelly N Roberts; Emma K Higgins; Adam D Bachstetter
Journal:  J Neurotrauma       Date:  2019-03-06       Impact factor: 5.269

9.  The functional roles of IGF-1 variants in the susceptibility and clinical outcomes of mild traumatic brain injury.

Authors:  Yu-Jia Wang; Henry Sung-Ching Wong; Chung-Che Wu; Yung-Hsiao Chiang; Wen-Ta Chiu; Kai-Yun Chen; Wei-Chiao Chang
Journal:  J Biomed Sci       Date:  2019-12-02       Impact factor: 8.410

10.  Time-dependent cytokine and chemokine changes in mouse cerebral cortex following a mild traumatic brain injury.

Authors:  David Tweedie; Hanuma Kumar Karnati; Roger Mullins; Chaim G Pick; Barry J Hoffer; Edward J Goetzl; Dimitrios Kapogiannis; Nigel H Greig
Journal:  Elife       Date:  2020-08-17       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.